Drug data last refreshed 13h ago · AI intelligence enriched 18h ago
Children's Advil Cold is a fixed-dose combination of ibuprofen (a nonsteroidal anti-inflammatory) and pseudoephedrine hydrochloride (a decongestant) formulated as an oral suspension for pediatric use. It is indicated for the temporary relief of cold and flu symptoms including fever, aches, and nasal congestion in children. The ibuprofen reduces fever and pain while the pseudoephedrine constricts nasal blood vessels to relieve congestion.
With LOE approaching and limited clinical development activity, the brand team is likely in maintenance/optimization mode with reduced headcount growth potential.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Children's Advil Cold offers experience in established brand management, OTC marketing, and pediatric market dynamics, but limited growth trajectory given LOE approaching status. Career progression would be better served by transfer to growth-stage products or a transition to strategic portfolio roles managing the LOE transition.
Worked on CHILDREN'S ADVIL COLD at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.